Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Chlorphentermine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 known ✓ | P31645 | 3/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 3/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 1.00 |
| ▸ | HTR2A | P28223 | 1/20 | 1.00 |
| ▸ | HRH1 | P35367 | 1/20 | 1.00 |
| ▸ | HTR2B | P41595 | 1/20 | 1.00 |
| ▸ | CHRNA4 | P43681 | 1/20 | 1.00 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chlorphentermine SCHEMBL124013 | 0.98 | SLC6A2 (0.95) | SLC6A2SLC6A4SLC6A3HTR2AHRH1 | |
| Chlorphentermine SCHEMBL1885131 | 0.96 | SLC6A2 (0.91) | SLC6A2SLC6A4SLC6A3HTR2AHRH1 | |
| Chlorphentermine SCHEMBL10801397 | 0.94 | SLC6A4 (0.88) | SLC6A2SLC6A4SLC6A3HTR2AHRH1 | |
| Chlorphentermine SCHEMBL21773282 | 0.90 | SLC6A2 (0.81) | SLC6A2SLC6A4SLC6A3HTR2AHRH1 | |
| SCHEMBL14040447 | 0.82 | SLC6A4 (0.69) | SLC6A2SLC6A4SLC6A3HTR2AHRH1 | |
| SCHEMBL228926 | 0.80 | SLC6A2 (0.67) | SLC6A2SLC6A4SLC6A3HTR2AHRH1 | |
| SCHEMBL73498 | 0.80 | SLC6A4 (0.67) | SLC6A2SLC6A4SLC6A3HTR2AHRH1 | |
| SCHEMBL28848601 | 0.80 | SLC6A4 (0.67) | SLC6A2SLC6A4SLC6A3HTR2AHRH1 | |
| Iodide SCHEMBL6643449 | 0.79 | SLC6A2 (0.65) | SLC6A2SLC6A4SLC6A3HTR2AHRH1 | |
| Hydrochloric Acid SCHEMBL5831539 | 0.78 | SLC6A2 (0.64) | SLC6A2SLC6A4SLC6A3HTR2AHRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4178 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260027139-A1 | TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST | VIVUS, INC. | 2026-01-29 | — | — | US | claimed |
| US-20250295611-A1 | METHODS OF TREATING 5HT2A RECEPTOR-MEDIATED CONDITIONS | TESSELLATE THERAPEUTICS INC (US) | 2025-09-25 | — | — | US | claimed |
| EP-4145394-B1 | PERSONALIZED PERCEPTUAL VIDEO ENCODER FOR MISSION-CRITICAL TASKS | NOKIA TECHNOLOGIES OY (FI) | 2025-09-03 | — | — | EP | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-20240139224-A1 | TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST | AMERICAN ENTERTAINMENT PROPERTIES CORP., AS LENDER | 2024-05-02 | — | — | US | claimed |
| WO-2023212244-A1 | METHODS OF TREATING 5HT2A RECEPTOR-MEDIATED CONDITIONS | TESSELLATE THERAPEUTICS, INC. (US) | 2023-11-02 | — | — | WO | claimed |
| WO-2022199373-A1 | QUINAZOLINE COMPOUND AND USE OF PHARMACEUTICAL COMPOSITION | 上海璎黎药业有限公司 | 2022-09-29 | — | — | WO | claimed |
| WO-2022199375-A1 | PHARMACEUTICAL COMPOSITION OF QUINAZOLINE COMPOUND AND PREPARATION METHOD THEREFOR | 上海璎黎药业有限公司 | 2022-09-29 | — | — | WO | claimed |
| US-20220273600-A1 | LITHIUM SALTS OF N-SUBSTITUTED GLYCINE COMPOUNDS AND USES THEREOF | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2022-09-01 | — | — | US | claimed |
| CN-114746174-A | Low emission sorbent | 英格维蒂南卡罗来纳有限责任公司 | 2022-07-12 | — | — | CN | claimed |
| EP-0472598-B1 | DRY POWDER INHALATION DEVICE | ASTRA AB (SE) | 1996-07-03 | — | — | EP | claimed |
| EP-0470154-B1 | DRY POWDER INHALATION DEVICE | RIKER LABORATORIES INC (US) | 1996-06-05 | — | — | EP | claimed |
| EP-0705614-A1 | Dry powder inhalation device | RIKER LABORATORIES, INC. (US) | 1996-04-10 | — | — | EP | claimed |
| CN-1072602-A | Improve the enhanced dermal osmosis system of the local conveying of medicine | RICHARDSON VICKS INC (US) | 1993-06-02 | — | — | CN | claimed |
| EP-0470154-A1 | DRY POWDER INHALATION DEVICE. | RIKER LABORATORIES INC (US) | 1992-02-12 | — | — | EP | claimed |
| US-5019594-A | Method for decreasing appetite | INTERNEURON PHARMACEUTICALS, INC. (US) | 1991-05-28 | — | — | US | claimed |
| WO-1990013328-A1 | DRY POWDER INHALATION DEVICE | RIKER LABORATORIES, INC. (US) | 1990-11-15 | — | — | WO | claimed |
| WO-1990013327-A1 | DRY POWDER INHALATION DEVICE | RIKER LABORATORIES, INC. (US) | 1990-11-15 | — | — | WO | claimed |
| US-4557934-A | ALONG WITH A DIOL PYRROLIDONE OR AN AZACYCLOPENTAN-2-ONE | THE PROCTER & GAMBLE COMPANY (US) | 1985-12-10 | — | — | US | claimed |
| US-4255439-A | Means and method for aiding individuals to stop smoking | COOPER IRVING | 1981-03-10 | — | — | US | claimed |